Evidence method
Sequential · gp.financial.deposits
-1.05% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WABC · Dec 31, 2024
WESTAMERICA BANCORPORATION. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-25-001156Bank
Evidence method
Yoy · gp.fundamentals.net_income
-14.30% · CORE · VALID
Evidence method
Yoy · gp.financial.interest_income
-5.63% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20214/4 normalizedLevel 3Dec 31, 20214/4 normalizedLevel 3Mar 31, 20224/4 normalizedLevel 3Jun 30, 20224/4 normalizedLevel 3Sep 30, 20224/4 normalizedLevel 3Dec 31, 20224/4 normalizedLevel 3Mar 31, 20234/4 normalizedLevel 3Jun 30, 20234/4 normalizedLevel 3Sep 30, 20234/4 normalizedLevel 3Dec 31, 20234/4 normalizedLevel 3Mar 31, 20244/4 normalizedLevel 3Jun 30, 20243/3 normalizedLevel 3Sep 30, 20243/3 normalizedLevel 3Dec 31, 20243/3 normalizedLevel 3Mar 31, 20253/3 normalizedLevel 3Jun 30, 20254/4 normalizedLevel 3Sep 30, 20254/4 normalizedLevel 3Dec 31, 20254/4 normalizedLevel 3Mar 31, 20264/4 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -1.29%
- Current
- -1.05%
- Delta
- 0.24%
- Previous
- -15.73%
- Current
- -14.30%
- Delta
- 1.43%
- Previous
- -6.94%
- Current
- -5.63%
- Delta
- 1.30%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.